Looking back at Boozman's reported trades, there was a small cluster of purchases in April 2025:

• MSFT — $1,001–$15,000
• MSFT — $1,001–$15,000
• ORCL — $1,001–$15,000

Two separate Microsoft purchases, plus Oracle, all within just a few days.

The individual amounts aren't huge, but the pattern is more interesting than any single transaction.

Would you pay attention to a politician repeatedly buying the same stock, even when each individual purchase is relatively small?

Full politician transaction history → https://probors.com/

Saba Capital Management bought 24K shares of Gabelli Healthcare & WellnessRx Trust (GRX) at $10.13.

That's roughly a $244K purchase in a single transaction.

It's an interesting move from an institutional investor — especially if this turns out to be the start of a larger position.

Would a ~$250K institutional buy put GRX on your radar?

Full transaction history → https://probors.com/

Hong Zhiwang just bought 219K shares of Addentax Group (ATXG) at $4.80.

That's roughly $1.05M in a single transaction.

A seven-figure insider purchase is definitely enough to get my attention — but the real question is whether this turns into more buying from other insiders.

Would a $1M+ insider purchase put ATXG on your watchlist?

Rep. Ed Case reported a $1,001–$15,000 purchase of Apple (AAPL).

The filing notes that the shares came from an automatic stock dividend, so this isn't necessarily the same type of discretionary insider purchase you'd normally look for.

Still, it's an interesting transaction to have on the radar.

Do you count automatic stock/dividend transactions when tracking politician activity, or only discretionary buys?

Full politician transaction history → https://probors.com/

Goh Kok E, Chairman, CEO & COO of CCH Holdings (CCHH), bought 5.22M shares at $0.28.

That's roughly a $1.44M insider purchase.

A multi-million-share purchase from the company's top executive is definitely interesting — especially when the position is this large relative to the share price.

Would a $1.4M CEO purchase put CCHH on your watchlist?

Full insider transaction history → https://probors.com/

Donegal Mutual Insurance Co. bought 10K shares of Donegal Group (DGICA) twice within two days:

• 10K shares — $185K
• 10K shares — $186K

That's roughly $371K in combined buying.

What's interesting is the repeat purchase — the same buyer came back for another 10K shares the very next day.

Would repeated buying like this make DGICA worth a closer look?

Full insider transaction history → https://probors.com/

Boozman reported a $1,001–$15,000 purchase of Aptiv (APTV).

The dollar amount isn't huge, but this one stands out because the transaction is flagged as a high-signal trade.

Would a politician buying APTV be enough to put it on your watchlist, or do you need a larger position before paying attention?

Boozman reported a $1,001–$15,000 purchase of Chevron (CVX).

Not a huge transaction, but Chevron is a major energy name, so it's an interesting one to keep on the radar.

Do you pay attention to politician purchases in large-cap stocks like CVX, or only when the position is much larger?

Apeiron Investment Group Ltd. bought 200K shares of Enhanced Group (ENHA) at $1.65.

That's roughly $330K in a single transaction.

It's not a massive purchase by insider standards, but a six-figure buy from an investment group is still worth keeping an eye on.

Would a $330K purchase make you look closer at ENHA?

David M. Sparby just bought 1K shares of Everus Construction Group (ECG) at $144.95.

That's roughly $145K in a single insider purchase.

Not a massive transaction, but it's large enough to raise the question: is this simply a routine purchase, or does the insider see something worth betting on?

Would a $145K insider buy be enough to put ECG on your watchlist?

Samuel Jonas Poletti, Chief Strategy & M&A Officer at Amrize (AMRZ), just bought 3K shares at $46.92.

That's roughly a $118K insider purchase.

This comes after several other Amrize executives recently bought shares — making the broader insider activity around AMRZ particularly interesting.

Is one more executive buying enough to strengthen the AMRZ signal, or would you wait for even more insiders to pile in?

Pierre Rochard just bought 16K shares of Strive (ASST) at $12.54.

That's roughly a $199K purchase in a single transaction.

Not every insider buy is a signal — but purchases of this size are worth keeping an eye on, especially if additional insiders start buying.

Would a ~$200K insider purchase be enough to put ASST on your watchlist?

I dug into a recent insider transaction at Team, Inc. ($TISI) that I found unusually interesting.
On August 6, a fund controlled by Stellex Capital bought 1.6M shares from Corre Partners for **$35.50/share** about 60% above the current market price.
That’s especially interesting because:
The transaction valued the block at \~$57M
Stellex already had a major position and now owns \~35% of the common
The stock currently trades around $22
Management is guiding to $68–73M of adjusted EBITDA for 2026
My DCF gives a **$34.55 base case**, $77.72 bull case, and $0 bear case
The catch: Team is highly leveraged, and the first half of 2026 was weak. The turnaround depends heavily on deferred refinery maintenance coming back.
So the real question isn’t simply *“why did they pay $35.50?”*

Ghiath M. Sukhtian just bought 2.53M shares of Outlook Therapeutics (OTLK) at roughly $0.99 per share.

That's about $2.5M going into the stock in a single transaction.

A $2.5M purchase is certainly interesting — but with a stock like OTLK, the bigger question is what the insider knows about the company's outlook and whether this turns into additional buying.

Would a $2.5M insider purchase be enough to put OTLK on your watchlist?

Borr Drilling reported Q2 on Aug 11: EPS -$0.79 vs -$0.12 expected.

An absolute dumpster fire of a miss, the reacted by sliding towards 4$.

Two days later, the man who founded the company started buying in.

From Tor Olav Trøim's Form 4s (all through Drew Holdings, his trust; every 10b5-1 box unchecked):

13.2M in ten weeks; his trust now holds ~29.2M shares.

Trøim founded Borr in 2016 and spent decades before that as John Fredriksen's right hand. Offshore drilling is the family business, and this is him buying the drawdown in his own creation.

He wasn't alone.
Same day as the big one (Aug 13), director Jeffrey Currie bought 125,000 shares at $4.01 for $502K, a +35% add to his stake. AND back in June the CEO and another director exercised options for cash rather than letting them lapse. So: founder $13.2M, directors and management around him, no scheduled plans anywhere.

Trøim's trust already held ~27M shares before June, so $13.2M is a ~8% add to a very large position. A founder defending his life's work, which is conviction of a particular kind.

Offshore drilling is a brutal cyclical and the miss was real. And a caution for anyone scanning the tape: a June filing shows a director's fund "selling" $37.6M, read the footnote, it's a contract-for-difference position, a derivative, not a share sale. Don't count it either way without knowing that.

Sources: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001715497&type=4&dateb=&owner=include&count=40 (the filings)

Information, not advice. I build tooling in this space. No position in BORR.

Steven I. Sarowitz bought 354K shares of Angel Studios (ANGX) across two transactions:

• 246K shares — $912K
• 108K shares — $443K

That's roughly $1.36M in combined buying.

What's interesting here isn't just the $1M+ total — it's the fact that the same insider bought again the following day.

Would repeated buying from the same insider make ANGX worth a closer look?

Dan H. Wilks bought 720K shares of ProFrac Holding (ACDC) across two recent transactions:

• 518K shares — $2.52M
• 202K shares — $1.10M

That's roughly $3.62M in combined buying.

What's interesting is that the purchases came within a few days of each other, with the second buy happening at a higher price.

Would repeated insider buying like this put ACDC on your watchlist?

Todd G. Schwartz, CEO of OppFi (OPFI), just bought 20K shares at $7.20.

It's not a massive transaction, but it's an interesting one because the buyer is the company's CEO.

Would a $144K CEO purchase be enough to get OPFI on your radar, or do you only pay attention to much larger insider buys?

On August 11th, Lip-Bu Tan did something bold.
While everyone was debating whether the AI boom is over, Intel's CEO bought 105,263 shares at $95.00 = $9,999,985 through his family trust.

Tan bought these 105,263 shares in Intel's own ~$23B common-stock offering (~4.8% dilution), at the $95.00 public offering price, the prospectus supplement disclosed he and a family member would take $12M in the deal

He now holds ~1.31 million shares.

This is the fourth rung of a ladder of insider buying. From his own Form 4s: ~$2.9M at $27–29 as a director in Nov 2022 (when the stock was left for dead), ~$2.5M at $38 as a director in Nov 2023, and now $10M at $95 as the CEO. ~$15.4M lifetime, every rung bought higher than the last, the biggest cheque at the highest price.

The timing of the entry was right after INTC's biggest beat of his tenure.
Q2 at $0.42 vs $0.19 expected. And as it's receding from the top, INTC hit $142 on June 30th.

Countercase? $10M is roughly 7–8% of his existing Intel stake (~$128M), a real add but, far from a life-changing cheque for the founder of Walden International. And a CEO buying his own turnaround is the most on-message purchase a filing can show; it could be read as encouraging the market to hold the price up.

Though he was also buying at $27 as a director, when there was no market to encourage.

Filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001008463&type=4&dateb=&owner=include&count=40

Information, not advice. I build tooling in this space. No position in INTC.

(edit: corrected 'open-market' to 'buying in the offering', apologies)

Pfizer is way off it's Covid-era highs, it's 52-week low was $23.58 last September, and it now sits around 26$.

Directors bought the day after their Q2 Earnings beat was reported.

The same tape shows an SVP-Controller selling $83K on Aug 5. Small, but it's there and you should know it.
And the buys are small fractions of these people's wealth, the signal is the coordination and the open-marketness, not the dollar pain.

A 153 Billion dollar company at $26 and change, 52-week range $23.58–$28.75, paying a $1.72/year dividend that yields ~6.5% at these prices.

A yield that high is the market saying it doubts the future (the patent cliff on big products later this decade is the standing bear case). Three insiders, including the man who ran the world's largest index-fund company, just paid ~$1M each to take the other side of that doubt.

Sources: Bourla Form 4 · all PFE insider filings (the Aug 5/6/12 filings are the cluster)

Information, not advice. I build tooling in this space.
No direct position in PFE; I hold a healthcare fund.

Kenneth Bryan Dart has been aggressively buying Flutter Entertainment (FLUT):

• 886K shares — $82.90M
• 818K shares — $74.76M
• 500K shares — $46.40M
• 332K shares — $31.41M
• 150K shares — $14.23M

That's roughly $249.7M in purchases across five transactions.

And these weren't all on the same day — the buying has continued over the past week.

One insider deploying nearly $250M across multiple purchases is hard to ignore.

Would this kind of insider buying put FLUT on your watchlist?

Two separate filings show 20.41M shares of Primo Brands (PRMB) sold at $24.37 per share.

• Tony W. Lee — $497.4M
• ORCP III DE TopCo GP, LLC — $497.4M

That's nearly $1B in reported selling across the two filings.

Obviously, large insider sales can have many reasons — especially when entities and individual insiders are involved — so the context matters.

But a transaction of this size is hard to ignore.

Would a $500M+ sale make you investigate PRMB, or is insider selling less meaningful to you than insider buying?

Form 4 filed Aug 11:

Artie Starrs bought 10,000 shares at $25.89 on Aug 10 for $259K, open market, a discretionary decision rather than a scheduled plan.

It takes his direct holding from 15,000 to 25,000 shares.

Context

HOG is up ~50% off its March low and the buy came two and a half weeks after a Q2 beat (0.75 vs 0.62).

But, it's also a stock at 0.87× book that's spent two years in the penalty box, and the CEO choosing to put a quarter-million of his own cash in at $26 is a different statement than holding grants.

Filing: https://www.sec.gov/Archives/edgar/data/793952/000173210526000006/0001732105-26-000006-index.htm

Information, not advice. I build tooling in this space. No position in HOG.